- ISIN
- US88688T1007
- CUSIP
- 88688T100
- Sector
- Healthcare
- IPO Date
- Jul 19, 2018
Highlights
- EPS (TTM)
- -$25.09
- Total Revenue (TTM)
- $1.11B
- Gross Profit (TTM)
- $307.02M
- EBITDA (TTM)
- -$1.84B
- Year Range
- $3.76 - $23.20
- Target Price
- $10.00
- ROA (TTM)
- -87.23%
- ROE (TTM)
- -116.20%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
TLRY Performance Chart
Tilray, Inc. (TLRY) is down 49.2% since the beginning of the year. At $5 per share, TLRY is trading 80.2% below its 52-week high of $23. Investors who bought $1,000 worth of TLRY shares 5 years ago would now be looking at an investment worth $26.
Loading charts...
Returns By Period
Tilray, Inc. (TLRY) has returned -49.17% so far this year and 27.50% over the past 12 months.
Tilray, Inc.
- 1D
- -2.96%
- 1M
- -13.23%
- YTD
- -49.17%
- 6M
- -55.95%
- 1Y
- 27.50%
- 3Y*
- -32.91%
- 5Y*
- -51.78%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
TLRY Monthly Returns History
Based on dividend-adjusted daily data since Jul 19, 2018, TLRY's average daily return is +0.04%, while the average monthly return is +0.77%. At this rate, an investment would double in approximately 7.5 years.
Historically, 34% of months were positive and 66% were negative. The best month was Aug 2018 with a return of +195.0%, while the worst month was Mar 2020 at -52.3%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 9 months.
On a daily basis, TLRY closed higher 43% of trading days. The best single day was Sep 29, 2025 with a return of +60.9%, while the worst single day was Feb 11, 2021 at -49.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -17.39% | 5.50% | -17.79% | -3.55% | -11.70% | -16.70% | -49.17% | ||||||
| 2025 | -21.05% | -30.00% | -10.54% | -26.22% | -12.24% | -2.65% | 40.18% | 137.56% | 25.36% | -22.54% | -39.33% | 11.07% | -32.11% |
| 2024 | -20.43% | -5.46% | 42.77% | -0.00% | -27.13% | -7.78% | 22.29% | -15.76% | 2.92% | -6.82% | -18.29% | -0.75% | -42.17% |
| 2023 | 20.45% | -12.65% | -10.60% | -7.11% | -28.94% | -6.59% | 62.18% | 17.00% | -19.26% | -24.69% | 0.56% | 27.07% | -14.50% |
| 2022 | -15.22% | 2.35% | 27.38% | -35.91% | -9.84% | -30.51% | 16.99% | 4.11% | -27.63% | 48.00% | -4.91% | -30.49% | -61.74% |
| 2021 | 119.13% | 34.59% | -6.69% | -19.31% | -9.11% | 8.46% | -19.19% | -6.30% | -17.53% | -8.77% | -1.75% | -30.53% | -14.89% |
Benchmark Metrics
Tilray, Inc. has an annualized alpha of -11.37%, beta of 1.52, and R2 of 0.07 versus S&P 500 Index. Calculated based on daily prices since July 19, 2018.
- This stock participated in 209.00% of S&P 500 Index downside but only 47.40% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.07 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -11.37%
- Beta
- 1.52
- R²
- 0.07
- Upside Capture
- 47.40%
- Downside Capture
- 209.00%
Return for Risk
Risk / Return Rank
TLRY ranks 56 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Tilray, Inc. (TLRY) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TLRY | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.82 | ||
| Sortino ratioReturn per unit of downside risk | -1.17 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.37 | -0.19 |
| Calmar ratioReturn relative to maximum drawdown | 0.35 | 2.78 | -2.43 |
| Martin ratioReturn relative to average drawdown | 0.53 | 12.44 | -11.91 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Tilray, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Tilray, Inc. was 99.83%, occurring on Jun 20, 2025. The portfolio has not yet recovered.
The current Tilray, Inc. drawdown is 99.79%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 selloff2025 | -99.83%Jun 2025 | 6y 9mo | — | 7y 9moSep 2018 - now |
2018 bear market2018 | -25.76%Jul 2018 | 8d | 17d | 25dJul 2018 - Aug 2018 |
Rate-hike selloffLate 2018 | -13.32%Sep 2018 | 1d | 4d | 5dSep 2018 - Sep 2018 |
Rate-hike selloffLate 2018 | -8.94%Sep 2018 | 0s | 3d | 3dSep 2018 - Sep 2018 |
2018 pullback2018 | -4.93%Aug 2018 | 0s | 1d | 1dAug 2018 - Aug 2018 |
Drawdown Indicators
| TLRY | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.83% | -56.78% | -43.05% |
Max Drawdown (1Y)Largest decline over 1 year | -78.14% | -9.10% | -69.04% |
Max Drawdown (3Y)Largest decline over 3 years | -89.12% | -18.90% | -70.22% |
Max Drawdown (5Y)Largest decline over 5 years | -98.07% | -25.43% | -72.64% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -99.79% | -1.80% | -97.99% |
Average DrawdownAverage peak-to-trough decline | -91.41% | -10.71% | -80.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 51.73% | 2.03% | +49.70% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Tilray, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Tilray, Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for TLRY relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, TLRY has a P/S ratio of 0.3. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with TLRY
Add Tilray, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with TLRY